Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 20;12(12):CD005072.
doi: 10.1002/14651858.CD005072.pub4.

Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery

Tatjana Gibbons  1 , Ektoras X Georgiou  2 , Ying C Cheong  3 , Michelle R Wise  4
Affiliations

Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery

Tatjana Gibbons et al. Cochrane Database Syst Rev. .

Abstract

Background: Endometriosis is a condition characterised by the presence of ectopic deposits of endometrial-like tissue outside the uterus, usually in the pelvis. The impact of laparoscopic treatment on overall pain is uncertain and a significant proportion of women will require further surgery. Therefore, adjuvant medical therapies following surgery, such as the levonorgestrel-releasing intrauterine device (LNG-IUD), have been considered to reduce recurrence of symptoms. OBJECTIVES: To determine the effectiveness and safety of post-operative LNG-IUD in women with symptomatic endometriosis.

Search methods: We searched the following databases from inception to January 2021: The Specialised Register of the Cochrane Gynaecology and Fertility Group, CENTRAL (which now includes records from two trial registries), MEDLINE, Embase, PsycINFO, LILACS and Epistemonikos. We handsearched citation lists of relevant publications, review articles, abstracts of scientific meetings and included studies. We contacted experts in the field for information about any additional studies.

Selection criteria: We included randomised controlled trials (RCTs) comparing women undergoing surgical treatment of endometriosis with uterine preservation who were assigned to LNG-IUD insertion, versus control conditions including expectant management, post-operative insertion of placebo (inert intrauterine device), or other medical treatment such as gonadotrophin-releasing hormone agonist (GnRH-a) drugs.

Data collection and analysis: Two review authors independently selected studies for inclusion, and extracted data to allow for an intention-to-treat analysis. For dichotomous data, we calculated the risk ratio (RR) and 95% confidence interval (CI) using the Mantel-Haenszel fixed-effect method. For continuous data, we calculated the mean difference (MD) and 95% CI using the inverse variance fixed-effect method.

Main results: Four RCTs were included, with a total of 157 women. Two studies are ongoing. The GRADE certainty of evidence was very low to low. The certainty of evidence was graded down primarily for serious risk of bias and imprecision. LNG-IUD versus expectant management Overall pain: No studies reported on the primary outcome of overall pain. Dysmenorrhoea: We are uncertain whether LNG-IUD improves dysmenorrhoea at 12 months. Data on this outcome were reported on by two RCTs; meta-analysis was not possible (RCT 1: delta of median visual analogue scale (VAS) 81 versus 50, P = 0.006, n = 55; RCT 2: fall in VAS by 50 (35 to 65) versus 30 (25 to 40), P = 0.021, n = 40; low-certainty evidence). Quality of life: We are uncertain whether LNG-IUD improves quality of life at 12 months. One trial demonstrated a change in total quality of life score with postoperative LNG-IUD from baseline (mean 61.2 (standard deviation (SD) 14.8) to 12 months (mean 70.3 (SD 16.2) compared to expectant management (baseline 55.1 (SD 17.0) to 57.0 (SD 33.2) at 12 months) (n = 55, P = 0.014, very low-certainty evidence). Patient satisfaction: Two studies found higher rates of satisfaction with LNG-IUD compared to expectant management; however, combining the studies in meta-analysis was not possible (n = 95, very low-certainty evidence). One study found 75% (15/20) of those given post-operative LNG-IUD were "satisfied" or "very satisfied", compared to 50% (10/20) of those in the expectant management group (RR 1.5, 95% CI 0.90-2.49, 1 RCT, n=40, very low-certainty evidence). The second study found that fewer were "very satisfied" in the expectant management group when compared to LNG, but there were no data to include in a meta-analysis. Adverse events: One study found a significantly higher proportion of women reporting melasma (n = 55, P = 0.015, very low-certainty evidence) and bloating (n = 55, P = 0.021, very low-certainty evidence) following post-operative LNG-IUD. There were no differences in other reported adverse events, such as weight gain, acne, and headaches. LNG-IUD versus GnRH-a Overall pain: No studies reported on the primary outcome of overall pain. Chronic pelvic pain: We are uncertain whether LNG-IUD improves chronic pelvic pain at 12 months when compared to GnRH-a (VAS pain scale) (MD -2.0, 95% CI -20.2 to 16.2, 1 RCT, n = 40, very low-certainty evidence). Dysmenorrhoea: We are uncertain whether LNG-IUD improves dysmenorrhoea at six months when compared to GnRH-a (measured as a reduction in VAS pain score) (MD 1.70, 95%.CI -0.14 to 3.54, 1 RCT, n = 18, very low-certainty evidence). Adverse events: One study suggested that vasomotor symptoms were the most common adverse events reported with patients receiving GnRH-a, and irregular bleeding in those receiving LNG-IUD (n = 40, very low-certainty evidence) AUTHORS' CONCLUSIONS: Post-operative LNG-IUD is widely used to reduce endometriosis-related pain and to improve operative outcomes. This review demonstrates that there is no high-quality evidence to support this practice. This review highlights the need for further studies with large sample sizes to assess the effectiveness of post-operative adjuvant hormonal IUD on the core endometriosis outcomes (overall pain, most troublesome symptom, and quality of life).

PubMed Disclaimer

Conflict of interest statement

TG: nothing to declare

EG: nothing to declare

YC: lecturing Merck; minor share holdings Complete Fertility Ltd; previous advisory board contribution Merck, Ferring

MW: nothing to declare

Figures

1
1
2
2
Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
4
4
Chronic pelvic pain outcome ‐ LNG‐IUD Vs GnRH‐a
5
5
1.1
1.1. Analysis
Comparison 1: Postoperative use of LNG‐IUD compared with expectant treatment in women with endometriosis, Outcome 1: Patient satisfaction
2.1
2.1. Analysis
Comparison 2: Postoperative use of LNG‐IUD compared with GnRH‐a in women with endometriosis, Outcome 1: Chronic pelvic pain
2.2
2.2. Analysis
Comparison 2: Postoperative use of LNG‐IUD compared with GnRH‐a in women with endometriosis, Outcome 2: Dysmenorrhoea
See this image and copyright information in PMC

Update of

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Bayoglu 2011 {published data only}
    1. Bayoglu Tekin Y, Dilbaz B, Altinbas S K, Dilbaz S. Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: Levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue. Fertility and Sterility 2011;95 (2):492-6. - PubMed
Gomes 2007 {published data only (unpublished sought but not used)}
    1. Gomes MK, Ferriani RA, Rosa e Silva JC, Japur de Sá Rosa e Silva AC, Vieira CS, Cândido dos Reis FJ. The levonorgestrel-releasing intrauterine system and endometriosis staging. Fertility and Sterility 2007;87(5):1231-1234. [DOI: ] - PubMed
Tanmahasamut 2012 {published data only}
    1. Tanmahasamut P, Rattanachaiyanont M, Angsuwathana S, Techatraisak K, Indhavivadhana S, Leerasiri P. Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial. Obstetrics and Gynecology 2012;119(3):519-26. [PMID: ] - PubMed
Vercellini 2003 {published data only}
    1. Frontino G, Vercellini P, De Giorgi O, Aimi G, Zaina B, Crosignani PG. Levonorgestrel-releasing intrauterine device (Lng-IUD) versus expectant management after conservative surgery for symptomatic endometriosis. A pilot study. In: Fertility and Sterility. Vol. 77. 2002. - PubMed
    1. Vercellini P, Frontino G, De Giorgi O, Aimi G, Zaina B, Crosignani PG. Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study. Fertility and Sterility 2003;80(2):305-9. [PMID: ] - PubMed

References to studies excluded from this review

Acien 2019 {unpublished data only}
    1. Acién P, Acién M. Anastrozole and levonorgrestrel-releasing intrauterine device in the treatment of endometriosis: a randomized clinical trial. Preprints 2019;1:1-2. [DOI: 10.20944/preprints201911.0010.v1] - DOI - PMC - PubMed
Alhamdan 2010 {published data only (unpublished sought but not used)}
    1. Alhamdan D, Bignardi T, Hardas G, Merkur H, Condous G. Mirena intra-uterine system: does it improve long term symptoms in women with chronic pelvic pain and/or endometriosis after laparoscopy? A multicentre randomized controlled trial. Reviews on Recent Clinical Trials. 2010;5(3):143-6. [PMID: ] - PubMed
Carvalho 2018 {published data only}
    1. Carvalho N, Margatho D, Cursino K, Benetti-Pinto CL, Bahamondes L. Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial.. Fertility and Sterility 2018;110(6):1129-1136. [DOI: 10.1016/j.fertnstert.2018.07.003] - DOI - PubMed
Chen 2017 {published data only}
    1. Chen YJ. Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study. American Journal of Obstetrics and Gynecology 2017;216(6):582. [DOI: ] - PubMed
de Sá Rosa e Silva 2006 {published data only}
    1. Sá Rosa e Silva AC, Rosa e Silva JC, Nogueira AA, Petta CA, Abrão MS, Ferriani RA. The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis. Fertility and Sterility 2006;86(3):742-4. [PMID: ] - PubMed
Lee 2018 {published data only}
    1. Lee KH, Jung YW, Song SY, Kang BH, Yang JB, Ko YB, et al. Comparison of the efficacy of diegnogest and levonorgestrel-releasing intrauterine system after laparoscopic surgery for endometriosis. The Journal of Obstetric and Gynaecological Research 2018;44(9):1779-1786. [DOI: 10.1111/jog.13703] - DOI - PubMed
Lockhat 2005 {published data only}
    1. Lockhat FB, Emembolu JE, Konje JC. Serum and peritoneal fluid levels of levonorgestrel in women with endometriosis who were treated with an intrauterine contraceptive device containing levonorgestrel. Fertility and Sterility 2005;83:398-404. [PMID: ] - PubMed
Manetta 2008 {published data only}
    1. Manetta LA, Paula MW, Rosa e Silva JC, Sa Rosa e Silva ACJ, Nogueira AA, Ferriani RA. Uterine ultrasonographic changes during endometriosis treatment: a comparison between levonorgestrel-releasing intrauterine devices and a gonadotropin-releasing hormone agonist. Ultrasound in Medicine & Biology 2008;34(12):1914-8. [PMID: ] - PubMed
Margatho 2018 {published and unpublished data}
    1. Magartho D, Carvalho N, Eloy L, Bahmondes L. Assessment of biomarkers in women with endometriosis-associated pain using the ENG contraceptive implant or the 52 mg LNG-IUS: a non-inferiority randomised clinical trial. The European Journal of Contraception & Reproductive Health Care October 2018;23(5):344-350. [DOI: 10.1080/13625187.2018.1531117] - DOI - PubMed
Oh 2006 {published data only}
    1. Oh ST, Lim YT, Choi YM, Hur JY, Lee TH, Lee BS. The effect of combined treatment of Lng-ius and MPA for chronic pelvic pain of endometriosis. In: XVIII FIGO World Congress of Gynecology and Obstetrics. Vol. 2. 2006. [PNJ-47330788]
Petta 2005 {published data only}
    1. Petta CA, Ferriani RA, Abrao MS, Hassan D, Rosa E Silva JC, Podgaec S, Bahamondes L. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Human Reproduction 2005;20(7):1993-8. [PMID: ] - PubMed
Qiu 2017 {published data only}
    1. Qiu H, Yuan Z. Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study. American Journal of Obstetrics and Gynecology 2017;217(6):708. [DOI: ] - PubMed
Rosa e Silva 2005 {published data only}
    1. Rosa e Silva JC, Manetta LA, Rosa e Silva ACJS, Leite SR, Petta CA, Abrfio MS, et al. Effects of the levonorgestrel releasing intra-uterine system on uterine and ovarian volumes, endometrial thickness and dopplervelocimetry of uterinearteries, in women with pelvic endometriosis. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2005;123:S39-40. [CENTRAL: CN-00600347]
Seo 2018 {published data only}
    1. Seo SK, Kim MK, Noe EB, Yun BH, Lee BS. Clinical effects of levonorgestrel-releasing intrauterine device in patients with endometrioma after surgery and 6 cycles of gonadotropin releasing hormone agonist. International Journal of Gynecology and Obstetrics 2018;25(1):39-43.
Taneja 2017 {published data only}
    1. Taneja A, Kaur S, Soni RK, Bhanupriya KJ, Singla L. Evaluating the efficacy of levonorgestrel intrauterine system and danazol for relief of postoperative pain in endometriosis. Journal of Clinical and Diagnostic Research 2017;11(7):10-12. [DOI: 10.7860/JCDR/2017/24126.10272] - DOI - PMC - PubMed
Vieira 2007 {published data only}
    1. Vieira CS, Ferreira RA, Rosa e Silva JC, Rosa e Silva ACJS, Gomes MK, Ferriani RA. Comparative study of the influence of the levonorgestrel intra-uterine system and the GnRH analogues on cardiovascular risk markers in patients with endometriosis. Fertility and Sterility 2007;88:S211. [CENTRAL: CN-00635760]
Wong 2010 {published data only}
    1. Wong AYK, Tang LCH, Chin RKH. Levonorgestrel-releasing intrauterine system (Mirena) and depot medroxyprogesterone acetate (Depo-Provera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised controlled trial. Australian & New Zealand Journal of Obstetrics & Gynaecology 2010;50(3):273-9. [PMID: ] - PubMed
Yagamuti 2014 {published data only}
    1. Yamaguti, Erciliene M M, Brito, Milena B, Ferriani, Rui A, Garcia, Andrea A, Rosa-e-Silva, Julio C, Vieira, Carolina S. Comparison of the hemostatic effects of a levonorgestrel-releasing intrauterine system and leuprolide acetate in women with endometriosis: a randomized clinical trial.. Thrombosis research 2014;134:1193-1197. [DOI: ] - PubMed
Yucel 2018 {published data only}
    1. Yucel N, Baskent E, Karamustafaoglu BC, Goynumer G. The levonorgestrel-releasing intrauterine system is associated with a reduction in dysmenorrhoea and dyspareunia, a decrease in CA 125 levels, and an increase in quality of life in women with suspected endometriosis. Australia Blackwell Publishing 2018;58(5):560-563. [DOI: 10.1111/ajo.12773] - DOI - PubMed

References to studies awaiting assessment

Magos 2004 {published data only (unpublished sought but not used)}
    1. Magos AL. Post-operative levonorgestrel-releasing IUS treatment after conservative surgery for symptomatic endometriosis stage 1 to IV to reduce pelvic pain symptoms. The Royal Free Hampstead NHS Trust - National Research Register 2004.
Wang 2018 {published data only (unpublished sought but not used)}
    1. Wang Y. Effect of pretreatment with Levonorgestrel-Releasing Intrauterine System on FET outcomes in Women with endometriosis. Chinese Clinical Trials Registry 2018;1:1. [DOI: ]
Xu 2011 {published data only}
    1. Xu X-Wn, Wang L-D, Zhu X-Q, Yan L-Z, Guan Y-T, Zhu S-C, et al. [Levonorgestrel-releasing intrauterine system and combined oral contraceptives as conservative treatments for recurrent ovarian endometriosis: a comparative clinical study]. Chung-Hua i Hsueh Tsa Chih [Chinese Medical Journal] 2011;91(15):1047-50. [PMID: ] - PubMed

References to ongoing studies

Daoudom 2014 {published data only (unpublished sought but not used)}
    1. Daoudom K. Effectiveness of levonorgestrel-intrauterine system (LNG-IUS) versus depot medroxyprogesterone scetate (DMPA) in treatment of pelvic pain in clinically diagnosed endometriotic patients. ClinicalTrials.gov 2018. [CLINICALTRIALS.GOV IDENTIFIER: NCT02534688] [URL: https://clinicaltrials.gov/show/NCT02534688 2015;(): 2015]
Lee 2017 {published and unpublished data}
    1. Middleton LJ, Daniels JP, Weckesser A, Bhattacharya S. Preventing recurrence of endometriosis by means of long-acting progestogen therapy (PRE-EMPT): report of an internal pilot, multi-arm, randomised controlled trial incorporating flexible entry design and adaption of design based on feasibility of recruitment. Trials 11 March 2017;18:121. [DOI: ] - PMC - PubMed

Additional references

Acién 2021
    1. Acién P, Velasco I, Acién M . Anastrozole and levonorgrestrel-releasing intrauterine device in the treatment of endometriosis: a randomized clinical trial.. BMC Womens Health. 2021;21(1):211. [DOI: 10.1186/s12905-021-01347-9] - DOI - PMC - PubMed
ASRM 2006
    1. American Society for Reproductive Medicine. Endometriosis and infertility: The Practice Committee of the American Society for Reproductive Medicine. Fertility and Sterility 2006;86(5 Suppl):156-60. [PMID: ] - PubMed
Bafort 2020
    1. Bafort C, Beebeejaun Y, Tomassetti C, Bosteels J, Duffy JMN. Laparoscopic surgery for endometriosis. Cochrane Database of Systematic Reviews 2020, Issue 10. Art. No: CD011031. [DOI: 10.1002/14651858.CD011031.pub3] - DOI - PMC - PubMed
Ballard 2008
    1. Ballard KD, Seaman HE, Vries CS and Wright JT. Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study—Part 1. BJOG 2008;115:1382–1391. - PubMed
Bazot 2004
    1. Bazot M, Thomassin I, Hourani R, Cortez A, Darai E. Diagnostic accuracy of transvaginal sonography for deep pelvic endometriosis. Ultrasound in Obstetrics & Gynecology 2004;24(2):180-5. [MEDLINE: ] - PubMed
Beatty 2009
    1. Beatty MN, Blumenthal PD. The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability. The Clinical Risk Manager 2009;5(3):561-574. [DOI: 10.2147/tcrm.s5624] - DOI - PMC - PubMed
Bellelis 2010
    1. Beatty MN, Blumenthal PD. The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability.. Therapeutics and Clinical Risk Management 2009;5:561-574. [DOI: 10.2147/tcrm.s5624] - DOI - PMC - PubMed
Chen 2020
    1. Chen I, Veth VB, Choudhry AJ, Murji A, Zakhari A, Black AY, et al. Pre‐ and postsurgical medical therapy for endometriosis surgery. Cochrane Database of Systematic Reviews 2020, Issue 11. Art. No: CD003678. [DOI: 10.1002/14651858.CD003678.pub3] - DOI - PMC - PubMed
Covidence [Computer program]
    1. Covidence . Version accessed 20 January 2021. Melbourne, Australia: Veritas Health Innovation. Available at covidence.org.
Crosignani 1996
    1. Crosignani PG, Vercellini P, Biffignandi F, Costantini W, Cortesi I, Imparato E. Laparoscopy versus laparotomy in conservative surgical treatment for severe endometriosis. Fertility and Sterility 1996;66(5):706-11. [MEDLINE: ] - PubMed
Crosignani 1997
    1. Crosignani PG, Vercellini P, Mosconi P, Oldani S, Cortesi I, De Giorgi O. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstetrics and Gynecology 1997;90(2):257-63. [MEDLINE: ] - PubMed
Du 1999
    1. Du M, Shao O, Zhou X. Serum levels of levonorgestrel during long-term use of Norplant. Chung-Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics & Gynecology] 1999;34(6):363-5. - PubMed
Duepree 2002
    1. Duepree HJ, Senagore AJ, Delaney CP, Marcello PW, Brady KM, Falcone T. Laparoscopic resection of deep pelvic endometriosis with rectosigmoid involvement. Journal of the American College of Surgery 2002;195(6):754-8. [MEDLINE: ] - PubMed
Duffy 2020
    1. Duffy JMN, Hirsch M, Vercoe M, Abbott J, Barker C, Collura B, et al. Harmonising Outcomes and Outcome Measures for Endometriosis Research. A core outcome set for future endometriosis research: an international consensus development study. BJOG 2020;127(8):967-974. [DOI: 10.1111/1471-0528.16157] [PMID: ] - DOI - PubMed
Dunselman 2014
    1. Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D'Hooghe T, De Bie B, et al. ESHRE guideline: management of women with endometriosis. Human Reproduction 2014;29(3):400-412. [DOI: 10.1093/humrep/det457] - DOI - PubMed
Eskenazi 1997
    1. Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstetrics and Gynecology Clinics of North America 1997;24:235-238. - PubMed
Fedele 2001
    1. Fedele L, Bianchi S, Zancomoto G, Portuese A, Ricciardia R. Use of levonorgestrel-releasing intrauterine system in the treatment of rectovaginal endometriosis. Fertility and Sterility 2001;75:485-8. - PubMed
Fedele 2004
    1. Fedele L, Bianchi S, Zanconato G, Bettoni G, Gotsch F. Long-term follow-up after conservative surgery for rectovaginal endometriosis. American Journal of Obstetrics and Gynecology 2004;190(4):1020-4. [MEDLINE: ] - PubMed
Ford 2004
    1. Ford J, English J, Miles WA, Giannopoulos T. Pain, quality of life and complications following the radical resection of rectovaginal endometriosis. British Journal of Obstetrics and Gynaecology 2004;111(4):353-6. [MEDLINE: ] - PubMed
French 2004
    1. French R, Sorhaindo AM, Van Vliet H, Mansour DD, Robinson AA, Logan S, et al. Progestogen‐releasing intrauterine systems versus other forms of reversible contraceptives for contraception. Cochrane Database of Systematic Reviews 2004 , Issue 3. Art. No: CD001776. [DOI: 10.1002/14651858.CD001776.pub2] - DOI - PMC - PubMed
GRADEpro GDT [Computer program]
    1. GRADEpro GDT. Hamilton (ON): McMaster University (developed by Evidence Prime), 6 August 2021. Available at gradepro.org.
Guo 2009
    1. Guo SW. Recurrence of endometriosis and its control. Human Reproduction 2009;15(4):441-461. [DOI: 10.1093/humupd/dmp007] [PMID: ] - DOI - PubMed
Henderson 1991
    1. Henderson AF, Studd JWW. The role of definitive surgery and hormone replacement therapy in the treatment of endometriosis. In: Thomas E and Rock J, editors(s). Modern Approaches to Endometriosis. Dordrecht: Kulwer Academic Publishers, 1991:275-90.
Higgins 2011
    1. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/. [DOI: 10.1136/bmj.d5928] - DOI
Higgins 2021
    1. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.
Hirsch 2016
    1. Hirsch M, Du­y JM, Kusznir JO, Davis CJ, Plana MN, Khan KS. Variation in outcome reporting in endometriosis trials: a systematic review. American Journal of Obstetrics and Gynaecology 2016;214(4):452-464. - PubMed
Johnson 2017
    1. Johnson NP, Hummelshoj L, Adamson GD, Keckstein J, Taylor HS, Abrao MS, et al. World Endometriosis Society consensus on the classification of endometriosis. Human Reproduction 2017;32:315-324. - PubMed
Kennedy 2005
    1. Kennedy S, Bergqvist A, Chapron C, D'Hooghe T, Dunselman G, Greb R, et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Human Reproduction 2005;20(10):704-2698. [DOI: 10.1093/humrep/dei135] - DOI - PubMed
Krashin 2015
    1. Krashin J, Tang JH, Mody S, Lopez LM. Hormonal and intrauterine methods for contraception for women aged 25 years and younger. Cochrane Database of Systematic Reviews 2015 , Issue 3. Art. No: CD009805. [DOI: 10.1002/14651858.CD009805.pub3] - DOI - PMC - PubMed
Leonardi 2020
    1. Leonardi M, Gibbons T, Armour M, Wang R, Glanville E, Hodgson R, et al. When to Do Surgery and When Not to Do Surgery for Endometriosis: A Systematic Review and Meta-analysis. Journal of Minimally Invasive Gynecology 2020;27(2):390-407. [DOI: 10.1016/j.jmig.2019.10.014.] [PMID: ] - DOI - PubMed
Liberati 2009
    1. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700. [DOI: 10.1136/bmj.b2700] - DOI - PMC - PubMed
Lopez 2015
    1. Lopez LM, Bernholc A, Hubacher D, Gretchen Stuart G, Van Vliet HA. Immediate postpartum insertion of intrauterine device for contraception. Cochrane Database of Systematic Reviews 2015, Issue 3. Art. No: CD003036. [DOI: 10.1002/14651858.CD003036.pub3] - DOI - PMC - PubMed
Lou 2018
    1. Luo L, Luo B, Zheng Y, Zhang H, Jing L, Sidell N. Oral and intrauterine progestogens for atypical endometrial hyperplasia. Cochrane Database of Systematic Reviews 2018 , Issue 3. Art. No: CD009458. [DOI: 10.1002/14651858.CD009458.pub3] - DOI - PMC - PubMed
Luciano 1988
    1. Luciano AA, Turksoy RN, Carleo J. Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis. Obstetrics and Gynecology 1988;72:323-7. - PubMed
Maruo 2001
    1. Maruo T, Laoag-Fernandez JB, Pakarinen P, Murakoshi H, Spitz IM, Johansson E. Use of a levonorgestrel intrauterine system on proliferation and apoptosis in the endometrium. Human Reproduction 2001;16:2103-8. - PubMed
Moghissi 1999
    1. Moghissi K. Medical treatment of endometriosis. Clinical Obstetrics and Gynecology 1999;42:620-32. [PMID: PMID: 10465472] - PubMed
NICE 2004
    1. National Collaborating Centre for Women's and Children's Health, National Institute for Clinical Excellence. Fertility: assessment and treatment for people with fertility problems. Royal College of Obstetrics and Gynaecology (RCOG) 2004.
Nicklin 1999
    1. Nicklin JL, Perrin L, Phillips G. Radical surgery for endometriosis. The Australian & New Zealand Journal of Obstetrics & Gynaecology 1999;39(1):68-74. [MEDLINE: ] - PubMed
Nilsson 1978
    1. Nilsson CG, Luukkainen T, Arko H. Endometrial morphology of women using a D-norgestrel releasing intrauterine device. Fertility and Sterility 1978;29:397-401. - PubMed
Nirgianakis 2020
    1. Nirgianakis K, Ma L, McKinnon B, Mueller MD. Recurrence Patterns after Surgery in Patients with Different Endometriosis Subtypes: A Long-Term Hospital-Based Cohort Study. Journal of Clinical Medicine 2020;9(2):496. [DOI: 10.3390/jcm9020496] - DOI - PMC - PubMed
RevMan Web 2021 [Computer program]
    1. Review Manager Web (RevMan Web). Version 2.6.0. The Cochrane Collaboration, 2021. Available at revman.cochrane.org.
Rodriguez 2020
    1. Rodriguez MB, Lethaby A, Jordan V. Progestogen‐releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2020, Issue 4. Art. No: CD002126. [DOI: 10.1002/14651858.CD002126.pub4] - DOI - PMC - PubMed
Sampson 1927
    1. Sampson JA. Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation. The American Journal of Pathology 1927;3(143):93–110. - PMC - PubMed
Seracchioli 2008
    1. Seracchioli R, Mabrouk M, Guerrini M, Manuzzi L, Savelli L, Frascà C and Venturoli S. Dyschezia and posterior deep infiltrating endometriosis: analysis of 360 cases. Journal of Minimally Invasive Gynecology 2008;15:695-699. - PubMed
Shakiba 2008
    1. Shakiba K, Bena JF, McGill KM, Minger J, Falcone T. Surgical treatment of endometriosis: a 7-year follow-up on the requirement for further surgery. Obstetrics & Gynecology 2008;111(6):1285-1292. [PMID: ] - PubMed
Silverberg 1986
    1. Silverberg SG, Haukkamaa M, Arko H, Nilsson CG, Luukkainen T. Endometrial morphometry of women during long term use of levonorgestrel intrauterine system. International Journal of Gynecological Pathology 1986;5:235-41. - PubMed
Sutton 1994
    1. Sutton CJ, Ewen SP, Whitelaw N, Haines P. Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis. Fertility and Sterility 1994;62(4):696-700. - PubMed
Tal 2019
    1. Tal A, Tal R, Pluchino N, and Taylor, H S. Endometrial cells contribute to preexisting endometriosis lesions in a mouse model of retrograde menstruation. Biology of Reproduction 2019;100:1453–1460. [DOI: doi: 10.1093/biolre/ioz039] - PMC - PubMed
Thomassin 2004
    1. Thomassin I, Bazot M, Detchev R, Barranger E, Cortez A and Darai E. Symptoms before and after surgical removal of colorectal endometriosis that are assessed by magnetic resonance imaging and rectal endoscopic sonography. American Journal of Obstetrics and Gynecology 2004;190:1264-1271. - PubMed
Vercellini 1996
    1. Vercellini P, Trespidi L, De Giorgi O, Cortesi I, Parazzini F, Crosignani PG. Endometriosis and pelvic pain: relation to disease stage and localization. Fertility and Sterility 1996;65(2):299-304. [MEDLINE: ] - PubMed
Vercellini 1998
    1. Vercellini P, De Giorgi O, Pesole A, Zaina B, Pisacreta A, Crosignani PG. Prevention of recurrences by postoperative medical treatment. In: Lemay A, Maheux R, editors(s). Understanding and Managing Endometriosis. Advances in research and practice. Quebec City: Parthenon Publishing, 1998:261-8.
Vercellini 2000
    1. Vercellini P, De Giorgi O, Pisacreta A, Pesole AP, Vicentini S, Crosignani PG. Surgical management of endometriosis. Best Practice & Research. Clinical Obstetrics & Gynaecology 2000;14(3):501-23. [MEDLINE: ] - PubMed
Vigano 2007
    1. Viganò P, Somigliana E, Vercellini P. Levonorgestrel-releasing intrauterine system for the treatment of endometriosis: biological and clinical evidence. Womens Health 2007;3(2):207-214. [DOI: 10.2217/17455057.3.2.207] [PMID: ] - DOI - PubMed

References to other published versions of this review

Abou‐Setta 2013
    1. Abou-Setta A, Houston B, Al-lnany H, Farquhar C. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery. Cochrane Database Systematic Reviews 2013;1:1-27. [DOI: 10.1002/14651858.CD005072.pub3] - DOI - PubMed

Publication types